How can we integrate the biology of breast cancer cell dormancy into clinical practice?
Cancer Cell
; 42(7): 1147-1151, 2024 Jul 08.
Article
em En
| MEDLINE
| ID: mdl-38906154
ABSTRACT
Clinical practice and clinical research heavily rely on primary tumors, circulating tumor DNA, and/or overt metastases as sources of material for predicting or investigating breast cancer metastatic relapses. However, these approaches do not consider emerging fundamentals in the biology of metastatic dormancy and relapse. Conversely, the field of metastatic dormancy often discounts key clinical factors influencing relapse dynamics (e.g., patient's age and overall health condition). Here, we delineate these disparities into four gaps and propose a framework to bridge them.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
Limite:
Female
/
Humans
Idioma:
En
Revista:
Cancer Cell
Ano de publicação:
2024
Tipo de documento:
Article